29.12.2020 12:11:48
|
Amphastar Pharma: FDA Approves Glucagon For Injection Emergency Kit, 1 Mg - Quick Facts
(RTTNews) - Amphastar Pharmaceuticals, Inc. (AMPH) said the FDA has approved its Abbreviated New Drug Application for Glucagon for Injection Emergency Kit, 1 mg. Glucagon is indicated for the treatment of severe hypoglycemia and is also used as a diagnostic aid. The company plans to launch Glucagon for Injection Emergency Kit, which it previously referred to as AMP-001, within two months.
Amphastar's CEO, Jack Zhang, stated: "This approval is yet another milestone for the Company and marks the first-ever FDA approval of a generic version of rDNA Glucagon."
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amphastar Pharmaceuticals Incmehr Nachrichten
05.11.24 |
Ausblick: Amphastar Pharmaceuticals informiert über die jüngsten Quartalsergebnisse (finanzen.net) |
Analysen zu Amphastar Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
Amphastar Pharmaceuticals Inc | 31,04 | 0,36% |
|